ALAI MUMIYO (SHILAJIT): TRADITIONAL ORIGINS AND EXPERIMENTAL EVIDENCE OF ANTICOAGULANT AND FIBRINOLYTIC ACTIVITY Article Swipe
The effect of Alai mumiyo extract (25 mg/kg) on blood coagulation in dogs was studied. Ten healthy animals received the extract orally, and coagulation parameters were measured at baseline, 30, and 60 minutes. The extract significantly prolonged clotting, recalcification, and thrombin times, increased plasma tolerance to heparin, and enhanced fibrinolytic activity (p < 0.05). Fibrinogen levels slightly decreased, while coagulation factor activities and total protein remained unchanged. Alai mumiyo exhibits anticoagulant and fibrinolytic effects, indicating potential for natural modulation of hemostasis.
Related Topics
Concepts
Metadata
- Type
- article
- Landing Page
- https://doi.org/10.5281/zenodo.17535342
- OA Status
- green
- OpenAlex ID
- https://openalex.org/W7104016921
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W7104016921Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.5281/zenodo.17535342Digital Object Identifier
- Title
-
ALAI MUMIYO (SHILAJIT): TRADITIONAL ORIGINS AND EXPERIMENTAL EVIDENCE OF ANTICOAGULANT AND FIBRINOLYTIC ACTIVITYWork title
- Type
-
articleOpenAlex work type
- Publication year
-
2025Year of publication
- Publication date
-
2025-11-05Full publication date if available
- Authors
-
Zagrutdinov, FanilList of authors in order
- Landing page
-
https://doi.org/10.5281/zenodo.17535342Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.5281/zenodo.17535342Direct OA link when available
- Concepts
-
Coagulation, Fibrinogen, Anticoagulant, Medicine, Pharmacology, Fibrinolysis, Thromboplastin, Blood coagulation factors, Clot formation, Protein C, Thrombin, Thrombin time, Coagulation system, Tissue factor, Internal medicine, Immunology, Hemostasis, Whole blood, Endocrinology, Fibrinolytic agentTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
Full payload
| id | https://openalex.org/W7104016921 |
|---|---|
| doi | https://doi.org/10.5281/zenodo.17535342 |
| ids.doi | https://doi.org/10.5281/zenodo.17535342 |
| ids.openalex | https://openalex.org/W7104016921 |
| fwci | 0.0 |
| type | article |
| title | ALAI MUMIYO (SHILAJIT): TRADITIONAL ORIGINS AND EXPERIMENTAL EVIDENCE OF ANTICOAGULANT AND FIBRINOLYTIC ACTIVITY |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T12548 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.22033892571926117 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2720 |
| topics[0].subfield.display_name | Hematology |
| topics[0].display_name | Hemostasis and retained surgical items |
| topics[1].id | https://openalex.org/T12322 |
| topics[1].field.id | https://openalex.org/fields/34 |
| topics[1].field.display_name | Veterinary |
| topics[1].score | 0.16580504179000854 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/3404 |
| topics[1].subfield.display_name | Small Animals |
| topics[1].display_name | Animal health and immunology |
| topics[2].id | https://openalex.org/T10869 |
| topics[2].field.id | https://openalex.org/fields/11 |
| topics[2].field.display_name | Agricultural and Biological Sciences |
| topics[2].score | 0.03323794901371002 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1110 |
| topics[2].subfield.display_name | Plant Science |
| topics[2].display_name | Polysaccharides and Plant Cell Walls |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2778382381 |
| concepts[0].level | 2 |
| concepts[0].score | 0.8099422454833984 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q179217 |
| concepts[0].display_name | Coagulation |
| concepts[1].id | https://openalex.org/C2779036427 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7412331104278564 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q381899 |
| concepts[1].display_name | Fibrinogen |
| concepts[2].id | https://openalex.org/C2778205648 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5977188944816589 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q215118 |
| concepts[2].display_name | Anticoagulant |
| concepts[3].id | https://openalex.org/C71924100 |
| concepts[3].level | 0 |
| concepts[3].score | 0.5491024851799011 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[3].display_name | Medicine |
| concepts[4].id | https://openalex.org/C98274493 |
| concepts[4].level | 1 |
| concepts[4].score | 0.5275141000747681 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[4].display_name | Pharmacology |
| concepts[5].id | https://openalex.org/C2776825266 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4215333163738251 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1410794 |
| concepts[5].display_name | Fibrinolysis |
| concepts[6].id | https://openalex.org/C144594695 |
| concepts[6].level | 3 |
| concepts[6].score | 0.37074998021125793 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q6153218 |
| concepts[6].display_name | Thromboplastin |
| concepts[7].id | https://openalex.org/C2910877098 |
| concepts[7].level | 3 |
| concepts[7].score | 0.3482237160205841 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q179217 |
| concepts[7].display_name | Blood coagulation factors |
| concepts[8].id | https://openalex.org/C2908581485 |
| concepts[8].level | 3 |
| concepts[8].score | 0.34486865997314453 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q179217 |
| concepts[8].display_name | Clot formation |
| concepts[9].id | https://openalex.org/C2781287897 |
| concepts[9].level | 2 |
| concepts[9].score | 0.34011930227279663 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q412810 |
| concepts[9].display_name | Protein C |
| concepts[10].id | https://openalex.org/C2777292125 |
| concepts[10].level | 3 |
| concepts[10].score | 0.33105766773223877 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q409166 |
| concepts[10].display_name | Thrombin |
| concepts[11].id | https://openalex.org/C2780077467 |
| concepts[11].level | 4 |
| concepts[11].score | 0.3259047567844391 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q2520736 |
| concepts[11].display_name | Thrombin time |
| concepts[12].id | https://openalex.org/C3020712002 |
| concepts[12].level | 3 |
| concepts[12].score | 0.31381115317344666 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q179217 |
| concepts[12].display_name | Coagulation system |
| concepts[13].id | https://openalex.org/C186738567 |
| concepts[13].level | 3 |
| concepts[13].score | 0.3087024688720703 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q412841 |
| concepts[13].display_name | Tissue factor |
| concepts[14].id | https://openalex.org/C126322002 |
| concepts[14].level | 1 |
| concepts[14].score | 0.30564215779304504 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[14].display_name | Internal medicine |
| concepts[15].id | https://openalex.org/C203014093 |
| concepts[15].level | 1 |
| concepts[15].score | 0.27728793025016785 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[15].display_name | Immunology |
| concepts[16].id | https://openalex.org/C2778589496 |
| concepts[16].level | 2 |
| concepts[16].score | 0.26136165857315063 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q487937 |
| concepts[16].display_name | Hemostasis |
| concepts[17].id | https://openalex.org/C1621761 |
| concepts[17].level | 2 |
| concepts[17].score | 0.2535063922405243 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q7997549 |
| concepts[17].display_name | Whole blood |
| concepts[18].id | https://openalex.org/C134018914 |
| concepts[18].level | 1 |
| concepts[18].score | 0.2515997886657715 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[18].display_name | Endocrinology |
| concepts[19].id | https://openalex.org/C2909817843 |
| concepts[19].level | 3 |
| concepts[19].score | 0.2513476610183716 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q575222 |
| concepts[19].display_name | Fibrinolytic agent |
| keywords[0].id | https://openalex.org/keywords/coagulation |
| keywords[0].score | 0.8099422454833984 |
| keywords[0].display_name | Coagulation |
| keywords[1].id | https://openalex.org/keywords/fibrinogen |
| keywords[1].score | 0.7412331104278564 |
| keywords[1].display_name | Fibrinogen |
| keywords[2].id | https://openalex.org/keywords/anticoagulant |
| keywords[2].score | 0.5977188944816589 |
| keywords[2].display_name | Anticoagulant |
| keywords[3].id | https://openalex.org/keywords/fibrinolysis |
| keywords[3].score | 0.4215333163738251 |
| keywords[3].display_name | Fibrinolysis |
| keywords[4].id | https://openalex.org/keywords/thromboplastin |
| keywords[4].score | 0.37074998021125793 |
| keywords[4].display_name | Thromboplastin |
| keywords[5].id | https://openalex.org/keywords/blood-coagulation-factors |
| keywords[5].score | 0.3482237160205841 |
| keywords[5].display_name | Blood coagulation factors |
| keywords[6].id | https://openalex.org/keywords/clot-formation |
| keywords[6].score | 0.34486865997314453 |
| keywords[6].display_name | Clot formation |
| language | |
| locations[0].id | doi:10.5281/zenodo.17535342 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4306400562 |
| locations[0].source.issn | |
| locations[0].source.type | repository |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Zenodo (CERN European Organization for Nuclear Research) |
| locations[0].source.host_organization | https://openalex.org/I67311998 |
| locations[0].source.host_organization_name | European Organization for Nuclear Research |
| locations[0].source.host_organization_lineage | https://openalex.org/I67311998 |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | |
| locations[0].raw_type | article-journal |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | False |
| locations[0].is_published | |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.5281/zenodo.17535342 |
| indexed_in | datacite |
| authorships[0].author.id | |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Zagrutdinov, Fanil |
| authorships[0].countries | UZ |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210161197 |
| authorships[0].affiliations[0].raw_affiliation_string | Andijan State Medical Institute, Department of Pharmacology, Clinical Pharmacology, and Medical Biotechnology. |
| authorships[0].institutions[0].id | https://openalex.org/I4210161197 |
| authorships[0].institutions[0].ror | https://ror.org/https://ror.org/01ga8zd22 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210161197 |
| authorships[0].institutions[0].country_code | UZ |
| authorships[0].institutions[0].display_name | Andijan State Medical Institute |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Zagrutdinov, Fanil |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Andijan State Medical Institute, Department of Pharmacology, Clinical Pharmacology, and Medical Biotechnology. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.5281/zenodo.17535342 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-11-06T00:00:00 |
| display_name | ALAI MUMIYO (SHILAJIT): TRADITIONAL ORIGINS AND EXPERIMENTAL EVIDENCE OF ANTICOAGULANT AND FIBRINOLYTIC ACTIVITY |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T04:12:42.849631 |
| primary_topic.id | https://openalex.org/T12548 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.22033892571926117 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2720 |
| primary_topic.subfield.display_name | Hematology |
| primary_topic.display_name | Hemostasis and retained surgical items |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.5281/zenodo.17535342 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4306400562 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Zenodo (CERN European Organization for Nuclear Research) |
| best_oa_location.source.host_organization | https://openalex.org/I67311998 |
| best_oa_location.source.host_organization_name | European Organization for Nuclear Research |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I67311998 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | |
| best_oa_location.raw_type | article-journal |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.5281/zenodo.17535342 |
| primary_location.id | doi:10.5281/zenodo.17535342 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4306400562 |
| primary_location.source.issn | |
| primary_location.source.type | repository |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Zenodo (CERN European Organization for Nuclear Research) |
| primary_location.source.host_organization | https://openalex.org/I67311998 |
| primary_location.source.host_organization_name | European Organization for Nuclear Research |
| primary_location.source.host_organization_lineage | https://openalex.org/I67311998 |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | |
| primary_location.raw_type | article-journal |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | False |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.5281/zenodo.17535342 |
| publication_date | 2025-11-05 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.< | 52 |
| abstract_inverted_index.(p | 51 |
| abstract_inverted_index.60 | 31 |
| abstract_inverted_index.at | 27 |
| abstract_inverted_index.in | 11 |
| abstract_inverted_index.of | 2, 79 |
| abstract_inverted_index.on | 8 |
| abstract_inverted_index.to | 45 |
| abstract_inverted_index.(25 | 6 |
| abstract_inverted_index.30, | 29 |
| abstract_inverted_index.Ten | 15 |
| abstract_inverted_index.The | 0, 33 |
| abstract_inverted_index.and | 22, 30, 39, 47, 62, 71 |
| abstract_inverted_index.for | 76 |
| abstract_inverted_index.the | 19 |
| abstract_inverted_index.was | 13 |
| abstract_inverted_index.Alai | 3, 67 |
| abstract_inverted_index.dogs | 12 |
| abstract_inverted_index.were | 25 |
| abstract_inverted_index.blood | 9 |
| abstract_inverted_index.total | 63 |
| abstract_inverted_index.while | 58 |
| abstract_inverted_index.0.05). | 53 |
| abstract_inverted_index.effect | 1 |
| abstract_inverted_index.factor | 60 |
| abstract_inverted_index.levels | 55 |
| abstract_inverted_index.mg/kg) | 7 |
| abstract_inverted_index.mumiyo | 4, 68 |
| abstract_inverted_index.plasma | 43 |
| abstract_inverted_index.times, | 41 |
| abstract_inverted_index.animals | 17 |
| abstract_inverted_index.extract | 5, 20, 34 |
| abstract_inverted_index.healthy | 16 |
| abstract_inverted_index.natural | 77 |
| abstract_inverted_index.orally, | 21 |
| abstract_inverted_index.protein | 64 |
| abstract_inverted_index.activity | 50 |
| abstract_inverted_index.effects, | 73 |
| abstract_inverted_index.enhanced | 48 |
| abstract_inverted_index.exhibits | 69 |
| abstract_inverted_index.heparin, | 46 |
| abstract_inverted_index.measured | 26 |
| abstract_inverted_index.minutes. | 32 |
| abstract_inverted_index.received | 18 |
| abstract_inverted_index.remained | 65 |
| abstract_inverted_index.slightly | 56 |
| abstract_inverted_index.studied. | 14 |
| abstract_inverted_index.thrombin | 40 |
| abstract_inverted_index.baseline, | 28 |
| abstract_inverted_index.clotting, | 37 |
| abstract_inverted_index.increased | 42 |
| abstract_inverted_index.potential | 75 |
| abstract_inverted_index.prolonged | 36 |
| abstract_inverted_index.tolerance | 44 |
| abstract_inverted_index.Fibrinogen | 54 |
| abstract_inverted_index.activities | 61 |
| abstract_inverted_index.decreased, | 57 |
| abstract_inverted_index.indicating | 74 |
| abstract_inverted_index.modulation | 78 |
| abstract_inverted_index.parameters | 24 |
| abstract_inverted_index.unchanged. | 66 |
| abstract_inverted_index.coagulation | 10, 23, 59 |
| abstract_inverted_index.hemostasis. | 80 |
| abstract_inverted_index.fibrinolytic | 49, 72 |
| abstract_inverted_index.anticoagulant | 70 |
| abstract_inverted_index.significantly | 35 |
| abstract_inverted_index.recalcification, | 38 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 1 |
| citation_normalized_percentile.value | 0.80648222 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |